Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles

Martha E. Stokely, Puja Garg, Manzoor A. Bhat, Peter Koulen

Producción científica: Articlerevisión exhaustiva

2 Citas (Scopus)

Huella

Profundice en los temas de investigación de 'Transient 5-(4-phenylbutoxy)psoralen (PAP-1) treatment dissociates developing pathologies in autoimmune optic neuritis into two distinct pathology profiles'. En conjunto forman una huella única.

Medicine and Dentistry

Neuroscience